SPR-210 (Myosin 18A/CD245) |
Monocytes, macrophages, T-cells, type II epithelial cells |
SP-A |
(53–57) |
CD14 |
Myeloid lineage cells |
SP-A and SP-D |
(58, 59) |
DC-SIGN |
Macrophages and dendritic cells |
SP-D |
(60) |
Calrecticulin/CD91 |
Macrophages, neutrophils |
SP-A and SP-D |
(61, 62) |
CD93 (C1qRp) |
Endothelial cells, platelets, neutrophils, monocytes, microglial cells, monocytes |
SP-A |
(63, 64) |
CR1 |
B cells, monocytes, neutrophils, monocytes, microglial cells |
SP-A |
(65) |
SIRPα |
Myeloid lineage cells |
SP-A and SP-D |
(61, 66, 67) |
SIRPβ |
Myeloid lineage cells |
SP-D |
(67) |
Osteoclast-Associated Receptor (OSCAR) |
CCR2+ monocytes |
SP-D |
(68) |
NKp46 |
NK cells |
SP-D |
(69) |
leukocyte‐associated Ig‐like receptreceptor‐1/2 (LAIR 1/2) |
T cells |
SP-D |
(70) |
Fc Receptor γII (FcγRII/CD32) |
Eosinophils |
SP-D |
(71) |
TLR2, TLR4 and MD-2 |
Myeloid lineage cells |
SP-A and SP-D |
(72–75) |
CR3 (CD11b/CD18) |
Macrophages |
SP-A |
(76, 77) |
Ig-Hepta (GPR116) |
Type II cells |
SP-D |
(78) |
Uroplakin Ia |
Bladder epithelial cells |
SP-D |
(79) |
Epidermal Growth Factor Receptor (EGFR) |
Human lung adenocarcinoma epithelial cell lines |
SP-D |
(80) |
Gp 340 |
Macrophages |
SP-A and SP-D |
(81, 82) |
MPO |
Neutrophils |
SP-A and SP-D |
(83) |
C1q |
Macrophages |
SP-A |
(84, 85) |
Immunoglobulins |
Soluble |
SP-A and SP-D |
(86, 87) |
Defensins |
Soluble |
SP-D |
(88, 89) |
Decorin |
Soluble |
SP-D |
(90) |